AI assistant
Poly Medicure Ltd Capital/Financing Update 2024
60661_rns_2024-06-29_faeee0e9-0382-4139-8393-ce24848d2db1.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Poly Medicure Limited
Regd. Office: 232 B, 3rd Floor, Okhla Industrial Estate,
Phase-III, New Delhi - 110 020 (INDIA)
T: +91-11-33550700, 47317000
E: [email protected] W: polymedicure.com
CIN: L 40300DL1995PLC066923
POLYMED
Date: 29th June, 2024
Scrip Code: - 531768
The Manager,
BSE Limited,
Department of Corporate Services,
Phirozee Jeejeebhoy Towers,
Dalal Street, Mumbai- 400001.
Scrip Code: - POLYMED
The Manager
National Stock Exchange of India Limited
Exchange Plaza, Plot No. C/1-Block-G
Bandra Kurla Complex, Bandra(E),
Mumbai-400051.
Subject: Outcome of the Board Meeting of the Company
Ref: Compliance of Regulation 30 and 33 of SEBI (LODR) Regulations, 2015
Dear Sir/Madam,
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 29th June, 2024, at 232-B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi-110020, has considered and approved the proposal for raising of funds through issuance of new securities by way Qualified Institutional Placement ("QIP") and seeking approval of the members by way of Special Resolution for the same and in this regard we wish to submit as under :-
a) The Board has considered and approved raising of funds to the tune of amount not exceeding INR 1,000 Crore (One Thousand Crore) through new issue of equity shares by way of qualified institutions placement, in accordance with the relevant provisions of applicable law and subject to approval of the Company's shareholders and receipt of applicable regulatory approvals.
b) The details as required under SEBI Listing Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13 July, 2023 with respect to issuance of securities is enclosed as Annexure A to this letter.
c) The Company will take shareholders' approval through postal ballot for the issuance of shares under Qualified Institutional Placement.
d) The Board has proposed to fix Friday, 28th June, 2024 as the cut-off date for the purpose of determining the name of shareholders) for the purpose of dispatch of Postal Ballot Notice along with the details of E-voting to the shareholders.
The Board has appointed Mr. P.K. Mishra of M/s. P.K. Mishra & Associates, Practicing Company Secretary as Scrutinizer to conduct the Postal ballot voting process in fair and transparent manner.
Plants : Plot No. 104-105 & 115-116, Sector-59, HSIIDC Industrial Area, Ballabgarh, Faridabad - 121004, Haryana (INDIA)
Plot No. 33-34, Sector-68, IMT, Faridabad - 121004, Haryana (INDIA) T : +91-129-4287000, 3355070
The Meeting was started at 11.00 am and concluded on 11:30 am.
Kindly take a note of the same for your further needful and oblige us.
Thanking You,
Yours Sincerely
For Poly Medicure Limited
AVINASH
CHANDR
A
Digitally signed by AVINASH CHANDRA
Date: 2024.06.29 11:45:55 +05'30"
Avinash Chandra Company Secretary
Enclose as above:
Annexure - A
| S.NO. | Particular | Details |
|---|---|---|
| 1. | Type of securities proposed to be issued (viz., equity shares, convertibles, etc. | Equity Shares |
| 2. | Type of issuance (further public offering, rights issue, depository receipts (ADR / GDR), qualified institutions placement, preferential allotment etc.) | Qualified institutional placements ("QIP") in accordance with the provisions of Chapter VI of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, Section 42 and other applicable provisions of the Companies Act, 2013, the Companies (Prospectus and Allotment of Securities) Rules, 2014, each as amended, and other applicable laws, or through any other permissible mode and/or combination thereof as may be considered appropriate under applicable law |
| 3 | Total number of securities proposed to be issued or the total amount for which the securities will be issued (approximately) | Up to an aggregate amount not exceeding Rs. 1,000 crores (One Thousand Crore) or an equivalent amount thereof (inclusive of such premium to face value as may be fixed on such Securities) at such price or prices as may be permissible under applicable law |
| 4 | In case of preferential issue the listed entity shall disclose the following additional details to the stock exchanges): | Not Applicable |
| 5 | In case of bonus issue the listed entity shall disclose the following additional details to the stock exchanges): | Not Applicable |
| 6 | In case of issuance of depository receipts (ADR/GDR) or FCCB the listed entity shall disclose following additional details to the stock exchange(s): | Not Applicable |
| 7 | In case of issuance of debt securities or other non-convertible securities the listed entity shall disclose following additional details to the stock exchange(s): | Not Applicable |
| 8 | Any cancellation or termination of proposal for issuance of securities including reasons thereof: | Not Applicable |
NATIONAL SECURITIES BANK